Michael A. Pisetsky, an officer at SI-BONE, Inc., has reported the sale of 29,665 shares of the company's common stock. This transaction, filed on November 2, 2026, is significant as it showcases the ongoing trading strategies employed by company executives in the medical instruments sector.

The filing indicates that the sale occurred on October 29, 2026, at a weighted average price of $22.105 per share. The transaction was executed as part of a 10b5-1 trading plan established on June 13, 2025, which allows for pre-arranged stock sales to avoid potential insider trading allegations.

Background

SI-BONE, Inc. is a company operating in the surgical and medical instruments and apparatus industry. The company is incorporated in Delaware and has its business address in San Jose, California. SI-BONE is known for its innovative solutions in the field of spinal surgery and related medical applications.

What the Filing Says

The filing reveals that Pisetsky sold a total of 29,665 shares, bringing his total ownership to 164,444 shares following the transaction. The filing states, "The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13, 2025." This indicates a pre-planned approach to the sale, which is common among executives to manage their stock holdings responsibly.

Impact

This sale may affect stakeholders, including investors and analysts monitoring insider trading activity at SI-BONE. The structured nature of the transaction under the 10b5-1 plan may provide reassurance regarding the legitimacy of the sale, potentially influencing market perceptions.

What's Next

The filing does not say what happens next.